These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37386758)

  • 21. Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib.
    Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T
    Thorac Cancer; 2019 Oct; 10(10):1879-1884. PubMed ID: 31414729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.
    Cenaj O; Ligon AH; Hornick JL; Sholl LM
    Am J Clin Pathol; 2019 Jun; 152(1):97-108. PubMed ID: 31115453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method.
    Zhang Y; Tang ET; Du Z
    PLoS One; 2016; 11(1):e0146784. PubMed ID: 26765781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of
    Schmitt C; Schulz AA; Winkelmann R; Smith K; Wild PJ; Demes M
    Oncotarget; 2021 Oct; 12(22):2273-2282. PubMed ID: 34733418
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of the effectiveness of fusion-induced asymmetric transcription assay-based reverse transcription droplet digital PCR for ALK detection in formalin-fixed paraffin-embedded samples from lung cancer.
    Liu Y; Wu S; Shi X; Lu L; Zhu L; Guo Y; Zhang L; Zeng X
    Thorac Cancer; 2020 Aug; 11(8):2252-2261. PubMed ID: 32543087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
    Ebrahimizadeh W; Guérard KP; Rouzbeh S; Bramhecha YM; Scarlata E; Brimo F; Patel PG; Jamaspishvili T; Aprikian AG; Berman D; Bartlett JMS; Chevalier S; Lapointe J
    J Mol Diagn; 2020 Oct; 22(10):1246-1263. PubMed ID: 32763409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
    Ross DS; Zehir A; Cheng DT; Benayed R; Nafa K; Hechtman JF; Janjigian YY; Weigelt B; Razavi P; Hyman DM; Baselga J; Berger MF; Ladanyi M; Arcila ME
    J Mol Diagn; 2017 Mar; 19(2):244-254. PubMed ID: 28027945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers.
    Shah AN; Sunderraj A; Finkelman B; See SH; Davis AA; Gerratana L; Wehbe F; Katam N; Mahalingam D; Gradishar WJ; Behdad A; Blanco L; Cristofanilli M
    Oncotarget; 2022; 13():273-280. PubMed ID: 35126865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer.
    Fan Y; Sun R; Wang Z; Zhang Y; Xiao X; Liu Y; Xin B; Xiong H; Lu D; Ma J
    J Cancer Res Clin Oncol; 2023 May; 149(5):1667-1677. PubMed ID: 35583827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.
    Christgen M; van Luttikhuizen JL; Raap M; Braubach P; Schmidt L; Jonigk D; Feuerhake F; Lehmann U; Schlegelberger B; Kreipe HH; Steinemann D
    Oncotarget; 2016 Dec; 7(50):82733-82740. PubMed ID: 27716627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of BRAF
    Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
    Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.
    Kim S; Lee J; Hong ME; Do IG; Kang SY; Ha SY; Kim ST; Park SH; Kang WK; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim DH; Kim KM
    PLoS One; 2014; 9(11):e111693. PubMed ID: 25372287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization.
    Tajiri R; Ooi A; Fujimura T; Dobashi Y; Oyama T; Nakamura R; Ikeda H
    Hum Pathol; 2014 Apr; 45(4):725-34. PubMed ID: 24491355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
    Gilson P; Levy J; Rouyer M; Demange J; Husson M; Bonnet C; Salleron J; Leroux A; Merlin JL; Harlé A
    Sci Rep; 2020 Oct; 10(1):16386. PubMed ID: 33009475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
    Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation-Selected Amplification droplet digital PCR: A new single nucleotide variant detection assay for TP53
    Hu L; Ji YY; Zhu P; Lu RQ
    Anal Chim Acta; 2024 Aug; 1318():342929. PubMed ID: 39067934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
    Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
    Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Putative Clinical Potential of
    Boldrin E; Mazza M; Piano MA; Alfieri R; Montagner IM; Magni G; Scaini MC; Vassallo L; Rosato A; Pilati P; Scapinello A; Curtarello M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.